Minutes of the third meeting of The Clinical Pharmaceutics and Technical Services Group (CPTS) SMPU on Thursday 9 th February 11:00 13:00

Transcription

1 Minutes of the third meeting of The Clinical Pharmaceutics and Technical Services Group (CPTS) SMPU on Thursday 9 th February 11:00 13:00 Present: Julian Smith (Chair) Colin Powell (Chief Pharmaceutical Mentor) Karen Davies (Hywel Dda HB) Simon Kingsbury (Cwm Taf HB) Marie Lehane (Minutes) Mark Oldcorne (Betsi Cadwaladr UHB) Martin Rees-Milton (Velindre Cancer Centre) Laura-Jayne Richings (Aneurin Bevan HB) Lee Samuel (Abertawe Bro Morganwg ULHB) Paul Spark (Cardiff & Vale UHB) 1. Apologies: There were no apologies received and all HB s were represented. 2. Minutes of previous meeting matters arising: 2.1 Minutes - agreed that the minutes were a true reflection of the issues discussed. 2.2 Action sheet Point 4.1: all information is now available on the QA Infozone. Point 7.1: New cartons are now on order and we are on course for implementation from July PS will book a proportion of what is left of the old stock to each HB. SK notified the group of some alerts in Europe regarding Bortezomib SK will forward the information he has to the group. 3. Pre reg. projects Standards and Dose Banding: 3.1 has sent the information he has to Janet Gilbertson but is yet to receive a response. MO & LS reported that there has been little progress in the North and Swansea due to staffing levels. However, MRM confirmed that Velindre will be ready to roll the new dose banding out from May this year for South Wales. MO suggested that it would be a good time to get the Task & Finish Group to get together and discuss a way forward. to approach Roger Walker regarding the possibility of using the modernisation monies towards locum technicians and pharmacists to help implement the dose banding across Wales. CP suggested that a simple audit by pre-reg s will at the very least provide an action plan for us to work to. to contact Janet Gilbertson and suggest a pre-reg audit on potential savings on dose banding in Wales. will provide Janet Gilbertson with a list of names who will be responsible for this project at each Health Board. 4. Training:

2 4.1 Pre reg Manual Feedback from the group was generally positive. Any further feedback to be sent to MO or Jacqueline Wilkinson in Wrexham. Copies will be forwarded to Education and Training Operation Group. PS confirmed that C&V will be swapping to this manual this year. 4.2 Welsh Technical Services Meeting Date has now been set for 8 th and 9 th May. This year it will be held at Cardiff University making use of their cleanrooms for demonstration of various equipment in order to look at the best practices for collaboration/modernisation. Day 2 will be more of a training format. suggested that it would be a good opportunity to update delegates on the modernisation money projects. invited the leads of each project to feedback (suggested 5 minutes per project). 4.3 Technician Training TSET portal Rachel Dixon will be at the Welsh Technical Services Meeting to demonstrate and discuss. 4.4 PTQA No one from Wales is going as far as the group are aware. CP suggested it may be worthwhile sending someone along to the Education and Training Sub Group meeting to promote this. 4.5 National Checking Accreditations in Technical Services (brought forward from AOB) PS provided feedback on the project which has been on going in the South West, this is progressing well with the support from the Chief Pharmacists in the region. PS informed the group that C&V have sent one pharmacist and one technician on the course, both of whom have passed and are ready to check. There is a National Checking Group meeting on 14 th February which will determine how this project is taken forward, although approval from the Chief Pharmacists in the South West will help. 5. Minimising Risk for PN in Children: 5.1 brings the groups attention to the paper circulated and notes the focus on standardisation. MO and LJR have both looked at this paper and noted some findings. Both to forward their findings to the rest of the group general consensus was that the technical side is quite good but there are some clinical issues. to ask Roger Walker and the WCPC what this paper s status is in Wales. to also check with the NHSPQA Committee on the impact around the UK. members to review and feedback to. This will be revisited at the next meeting. 6. Modernisation Monies Progress & Action Plans: 6.1 reported that the WAG were very pleased with the way in which the group went through the bidding process and are happy with how technical services are looking to progress. Roger Walker has indicated that he would like the group to submit bids again next year, even thought monies have not yet formally been confirmed as being available. It is likely that competition for money will be even harder next year and that they may not be exclusive to technical services. CP suggested inviting Roger and Karen to the meeting on 9 th May to hear about how the money is being spent throughout Wales.

3 6.2 QMS (MO) MO, and AB collaborated to look at demos from two companies (Q-Pulse and MasterControl). They have put together a URS and DQ. Q-Pulse were the successful bid MO circulated the estimate costs involved for the group to review. has contacted Robin Burfield who has been very helpful and agreed to do the work of putting the system onto the pharmacy server. Whilst this work will not be completed overnight, Robin is happy to carry it out and will not charge for it. MO circulated the estimated annual costs which each HB will be responsible for once the initial 5 year contract has expired. to ask Karen and Mark about capital charges as there may be scope to employ an external consultant to help implement this system with a portion of the money which has been allocated to the QMS project. MO suggested that the timescale for implementation will be April / May MO to discuss what is needed with Q-Pulse and create an action plan based on this. Once complete MO will circulate this to the group for comments. 6.3 Automation of Cyclophosphomide Syringes (PS) PS has placed an order for an isolator from Envair; arrival of which will coincide with preparation for the transfer of Aseptics to SMPU. and CP reiterated the importance of ensuring all the money is spent. 6.4 Preparation of Vaccines in Clinical Areas (MRM) Cabinets have arrived and the vaccines are due to arrive in April. MRM estimates implementation to be in May CP suggested that it would be good to publicise this via posters or papers so that WAG are well aware of how successfully this project has been completed. 6.5 Baxa Rapidfill (LJR) Change of plan on this project and Gwent have bought an isolator and Baxa pump instead. Delivery of these are due by the end of March. 6.6 Stability Cabinets (Andrew Sully) provided some feedback. AS has ordered two cabinets from Vindon. stated that an action plan of products is required ASAP. 6.7 Non Sterile Production Development (MO) MO has ordered a range of equipment in order to manufacture liquids, creams and ointments. 6.8 Automated Syringe Filling (MO) MO reported that BCUHB have agreed to transfer the monies for this over to next year although the order is likely to be places before the end of March. 6.9 Labelling (Alex Bosley) AB joined the meeting at this point. explained that each HB was given a proportion of money to order necessary software/equipment for this project. Some orders have already been received. invited members to suggest ideas on how to manage the training days. LJR reported that the set up of the software is very time consuming and that the creation of templates is not straight forward. AB informed the group that those without the software will first need to complete an installation process.

4 and AB to meet and propose a plan for the group/individuals and circulate to the group for comments Next Steps requested that PS share his previous work on collaboration concerning NPSA Alert 20 as a starting point. invited members to comment on this work and propose projects as a matter of urgency to enable an appropriate action plan to be prepared for CPTS. 7. The Resheathing of Needles in Relation to EC Rules: 7.1 MO reported that the Radiopharmacy group are concerned about the new EC rules. has highlighted this issue to the UKRPG. to raise this issue at the next NHSPQA meeting. MO & to keep an eye on this situation and report back as necessary. 8. Quality Standard for the Oncology Pharmacy Service: 8.1 LS circulated the paper and recommends that members look through and feedback to him with any comments. LS advised that due to the size of the document members should focus on the technical side only. 9. QMS URS and DQ (This item was covered under item 6.2) 10. AOB 10.1 Feedback from WCPC CP provides feedback from the last meeting. CP to circulate all relevant papers arising from the meeting to members of the group, CP reported that the main focus was on the workplan (copy was circulated to the group) detailing 7 key objectives. CP highlighted that the modernisation monies in technical services is one of the key objectives and noted that whilst this is a good sign for the group, the need to remain focussed on the tasks in hand are of the upmost importance. CP recommended that it would be worthwhile sending a representative on some of the other groups such as Patient Safety Group, NWIS IT Group and Service and Workforce Redesign Group. CP also reported that the AWDCC will be going through a process of reform, with a likely change in their terms of reference and also alterations in membership. CP reported that this group has had very positive feedback from WCPC but it is vital that we remain focussed on our purpose of modernisation and collaboration Overlabelling KD raised the issue of the cost of overlabelling from Neath Port Talbot. PS recommended that costing issues are discussed between ABMU and HB s who are not happy with the pricing. KD to ask Ken Thomas to raise this at the next AWDCC meeting. 11. Date of Next Meeting: Thursday 14 th June 2012, Wrexham Maelor Hospital

5 Actions No. Action Lead Target 2. Minutes of previous meeting matters arising: 7.1 Vinca Alkaloids PS to book out a proportion of what is left of the old stock to each HB. SK to forward information on alerts in Europe regarding Bortezomib. 3. Pre reg. projects Standards and Dose Banding: 3.1 The dose banding task and finish group to organise a meeting to discuss a way forward. to ask Roger Walker about using the modernisation monies towards locum technicians and pharmacists to assist with the dose banding project. to contact Janet Gilberston regarding a possible pre-reg audit on potential savings on dose banding in Wales. to send a list of names from each site who will be responsible for this project. 4. Training: 4.1 Feedback on the pre reg manual to be sent to MO or JW 4.2 Leads of each project to prepare feedback for the Welsh Technical Services Meeting on 8 th 9 th May. 4.4 Volunteers to attend the next E&T Group Meeting in order to promote attendance at PTQA to contact CP 5 Minimising Risk for PN in Children: 5.1 MO & LJR to forward their findings on this paper with the rest of the group. to contact RW and WCPC regarding the status of this paper in Wales. to also raise this at the next NHSPQA committee meeting. Members to review this paper and forward any feedback to. 6 Modernisation Monies Progress and Action Plans: 6.1 Roger and Karen to be invited to attend meeting on 9 th May to hear about how money is being spent. 6.2 to ask Karen and Mark about capital charges in relation to employing a consultant to assist implementation of this project. MO to discuss needs with Q-Pulse and draft and action plan and circulate for comments. 6.9 Members to contact with ideas on how to manage the Episys training days. HB s without the software to arrange initial installation. and AB to meet and propose an action plan for circulation and comments PS to share his previous work on collaborative working with the rest of the group. Members to comment and utilise this when drafting action plans. 7 The Resheathing of Needles in Relation to EC Rules: 7.1 to raise this issue at the next NHSPQA meeting PS SK MO/LS/MRM MO/AB/PS/ MRM/LJR/AS MO/LJR MO /AB PS/ MO & to keep an eye on the issue and provide any necessary feedback to the MO/ group. 8 Quality Standard for the Oncology Pharmacy Service: 8.1 Members to look at the technical issues within this document and feedback to LS.

6 10 AOB: 10.1 CP to circulate all relevant papers from last meeting to members of the group. Members to volunteer to represent Technical Services on the Patient Safety, NWIS IT and Service & Workforce Planning sub groups KD to ask Ken Thomas to raise cost of overlabelling at the next AWDCC meeting. CP KD